The Drive for the $1000 Genome
The race for next-generation sequencing kicks into gear.

Up Front


Clinical Research

In Every Issue 

  • Enabling Technologies
    FIRST BASE - Next-generation sequencing and adaptive trials are both gaining ground, and promise to profoundly impact medicine.
    By Kevin Davies
  • Entelos' First Year as a Public Company
    THE RUSSELL TRANSCRIPT - After going public last year, Entelos released its first financial report as a public company, and reports both gains and losses. 
    By John Russell
  • New Products